Gyon Technologies Capital Management, LP Axonics, Inc. Transaction History

Gyon Technologies Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$43.74 - $62.76 $1.69 Million - $2.43 Million	-38,739 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$50.01 - $73.35 $1.66 Million - $2.43 Million	33,097 Added 586.62%	38,739 $2.17 Million
Q3 2021 Nov 18, 2021	SELL	$59.21 - $78.66 $121,735 - $161,724	-2,056 Reduced 26.71%	5,642 $367,000
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $796,545 - $1.04 Million	-15,500 Reduced 66.82%	7,698 $488,000
Q1 2021 May 17, 2021	BUY	$49.14 - $59.89 $260,638 - $317,656	5,304 Added 29.64%	23,198 $1.39 Million
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $754,947 - $921,541	17,894 New	17,894 $893,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.